Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions

Hematology/Oncology Clinics of North America - United Kingdom
doi 10.1016/j.hoc.2011.05.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Potential Roles for PD‐1 and Cabozantinib in Patients With Metastatic Non‐Clear Cell Renal Cell Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Subtotal Distal Pancreatectomy for Metachronous Metastatic Renal Clear Cell Carcinoma

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2012English

Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma

Seminars in Nephrology
Nephrology
2020English

Clear Cell Papillary Renal Cell Carcinoma

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Safety and Efficacy of Sunitinib for Advanced Non-Clear Cell Renal Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2015English

Beta-1,4-Galactosyltransferase II Predicts Poor Prognosis of Patients With Non-Metastatic Clear-Cell Renal Cell Carcinoma

Tumor Biology
MedicineCancer Research
2017English

Prognostic Value of Granulocyte Colony-Stimulating Factor in Patients With Non-Metastatic Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2017English

Myoferlin Silencing Inhibits VEGFR2-mediated Proliferation of Metastatic Clear Cell Renal Cell Carcinoma

Scientific Reports
Multidisciplinary
2019English

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype

Clinical Genitourinary Cancer
OncologyUrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy